funding

Exclusive: Pfizer vet grabs $25M seed round to 'integrate' machine learning, genomics tech in drug R&D
Endpoints
Thu, 06/9/22 - 10:46 am
Pfizer
David Roblin
machine learning
funding
gemonics
R&D
Relation Therapeutics
AI specialist Charm Therapeutics launches with $50m Series A
Pharmaforum
Thu, 06/9/22 - 10:31 am
Charm Therapeutics
funding
artificial intelligence
drug discovery
BMS-Backed Transition Bio Scores $50M to Mine Biomolecular Condensates for Therapeutic Use
BioSpace
Thu, 06/2/22 - 07:25 pm
Transition Bio
funding
Bristol Myers Squibb
microfluidics
drug discovery
artificial intelligence
Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases
BioSpace
Thu, 06/2/22 - 10:35 am
Upstream Bio
funding
asthma
allergies
Sapience raises funding to advance cancer therapy programs
Pharmaceutical Business Review
Wed, 06/1/22 - 09:54 am
Sapience Therapeutics
funding
peptide therapeutics
cancer
Inceptor Bio generates $37m in funding round as it advances CAR-T platform into the clinic
Biopharma Reporter
Wed, 05/25/22 - 10:13 am
Inceptor Bio
CAR-T
funding
cell therapy
cancer
A new spinout wades into ovarian aging, armed with a seed round and experimental drugs from Mass General
Endpoints
Sun, 05/22/22 - 09:08 pm
Oviva Therapeutics
Women's Health
ovarian aging
funding
CAR T without the toxicity: Kelonia gets $50M for a new take on cell therapy
MedCity News
Sun, 05/22/22 - 09:06 pm
Kelonia Therapeutics
CAR-T
cell therapy
funding
Inceptor Bio raises $37m from Series A to advance CAR-T lead program
Pharmaceutical Business Review
Fri, 05/20/22 - 10:32 am
Inceptor Bio
funding
CAR-T
Bacteriophage producer Locus Biosciences raises $35m in financing
Biopharma Reporter
Fri, 05/20/22 - 10:18 am
Locus Biosciences
funding
bacteriophage
Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers
BioSpace
Thu, 05/19/22 - 10:52 am
Inceptor Bio
cancer
cell therapy
funding
Locus pulls in a modest Series B as it attempts to emulate oncology's precision medicine model in antibacterials
Endpoints
Wed, 05/18/22 - 10:32 am
Locus Biosciences
venture capital
funding
antibiotics
antibacterials
R&D
Laekna Therapeutics Raises $61 Million in Series D financing
BioSpace
Wed, 05/18/22 - 10:28 am
Laekna Therapeutics
funding
liver disease
cancer
With its lead gene therapy nearing the clinic, SwanBio leans heavily on Syncona to close $56M series B
Fierce Biotech
Wed, 05/18/22 - 10:25 am
Sycona
SwanBio Therapeutics
funding
gene therapy
Starna Therapeutics emerges with financing for mRNA vaccine and therapies
Endpoints
Mon, 05/16/22 - 10:38 am
Starna Therapeutics
funding
RSV
idiopathic pulmonary fibrosis
Against a historic market downturn, Moma Therapeutics raises $150M for precision cancer research
BioPharma Dive
Wed, 05/11/22 - 10:51 am
MOMA Therapeutics
funding
R&D
cancer
Inflammation space swells further as Nuvig unveils $47M to transform autoimmune therapies
Fierce Biotech
Wed, 05/11/22 - 10:30 am
Nuvig
inflammation
protein therapeutics
funding
Curebase bags $40m to develop patient-centric trials platform
Pharmaforum
Thu, 05/5/22 - 10:43 am
Curebase
clinical trials
funding
Apnimed closes $62.5M series C after working tirelessly on lead sleep disorder drug
Fierce Biotech
Wed, 05/4/22 - 05:41 pm
Apnimed
funding
obstructive sleep apnea
sleep apnea
Digital health firm Hello Heart raises $70m
Pharmaforum
Wed, 05/4/22 - 10:22 am
Medtech
digital health
mobile apps
funding
Hello Heart

Pages